In silico insights: QSAR modeling of TBK1 kinase inhibitors for enhanced drug discovery

Rumiana Tenchov,Julian Ivanov,Krittika Ralhan,Kavita Iyer,Shivangi Agarwal,Qiongqiong Angela Zhou

DOI: https://doi.org/10.26434/chemrxiv-2024-d2n98

2024-08-22

Abstract:TBK1, or TANK-binding kinase 1, is an enzyme that functions as a serine/threonine protein kinase. It plays a crucial role in various cellular processes, including the innate immune response to viruses, cell proliferation, apoptosis, autophagy, and anti-tumor immunity. Dysregulation of TBK1 activity can lead to autoimmune diseases, neurodegenerative disorders, and cancer. Due to its central role in these critical pathways, TBK1 is a significant focus of research for therapeutic drug development. In this paper, we explore data from the CAS Content Collection regarding TBK1 and its implication in a large assortment of diseases and disorders. With the demand for developing efficient TBK1 inhibitors been outlined, we focus on utilizing machine learning approach for developing predictive models for TBK1 inhibition, derived from the fragment-functional analysis descriptors. Using the extensive CAS Content Collection we assembled a training set of TBK1 inhibitors with experimentally measured IC50 values. We explored several machine learning techniques combined with various molecular descriptors to derive and select the best TBK1 inhibitor QSAR models. Certain significant structural alerts that potentially contribute to inhibition of TBK1 are outlined and discussed. The merit of the article stem from identifying the most adequate TBK1 QSAR models and subsequent successful development of advanced positive training data to facilitate and enhance drug discovery for an important therapeutic target such as TBK1 inhibitors, based on extensive, wide-ranging set of scientific information provided by the CAS Content Collection.

Chemistry

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to develop an effective prediction model for TBK1 kinase inhibitors to promote drug discovery. Specifically, the paper uses machine - learning methods to construct prediction models based on data extracted from the CAS content collection, using fragment - function analysis descriptors. These models are designed to help research scientists more effectively discover TBK1 inhibitors for various diseases such as cancer, viral infections, and inflammatory diseases. ### Main objectives of the paper: 1. **Develop prediction models**: Through machine - learning techniques, combined with multiple molecular descriptors, develop quantitative structure - activity relationship (QSAR) models that can accurately predict the activity of TBK1 inhibitors. 2. **Explain model mechanisms**: Not only develop models, but also explain the key molecular descriptors in the models in order to better understand the mechanisms of TBK1 inhibition. 3. **Improve drug discovery efficiency**: By providing efficient prediction tools, accelerate the drug research and development process for TBK1. ### Research background: - **Function of TBK1**: TBK1 (TANK - binding kinase 1) is a mitogen - activated protein kinase involved in multiple cellular processes, including innate immune responses, cell proliferation, apoptosis, autophagy, and anti - tumor immunity. Its dysfunction is related to various diseases such as autoimmune diseases, neurodegenerative diseases, and cancer. - **Research needs**: Due to the important role of TBK1 in various diseases, the development of effective TBK1 inhibitors has become an important goal in drug research and development. ### Methods: - **Data sources**: Collected a large number of experimental IC50 values of TBK1 inhibitors from the CAS content collection. - **Data processing**: Removed duplicate structures, records without structural information, salts, and mixtures, and finally obtained a training set of 1,183 compounds. - **Model development**: Used multiple machine - learning techniques (such as support vector machines, random forests, neural networks, etc.) and different molecular descriptors to construct and select the best QSAR models. - **Result analysis**: Identified and discussed structural alerts that are significant for TBK1 inhibition. ### Conclusions: - **Model performance**: Successfully developed multiple high - performance QSAR models that can accurately predict the activity of TBK1 inhibitors. - **Structural alerts**: Determined some important structural features that may have a significant impact on the inhibitory effect of TBK1. - **Application prospects**: These models and structural alerts provide valuable guidance for future drug discovery of TBK1 inhibitors. Through these efforts, the paper provides new tools and insights for drug discovery of TBK1 inhibitors and is expected to accelerate the research and development process of related drugs.

In silico insights: QSAR modeling of TBK1 kinase inhibitors for enhanced drug discovery

Identification of TBK1 inhibitors against breast cancer using a computational approach supported by machine learning

Bayesian machine learning to discover Bruton's tyrosine kinase inhibitors.

Identification of High-Affinity Inhibitors of TANK-Binding Kinase 1 (TBK1): A Promising Frontier for Controlling Inflammatory Signaling in Cancer

Combining structure-based pharmacophore modeling and machine learning for the identification of novel BTK inhibitors

Role of TBK1 Inhibition in Targeted Therapy of Cancer

Quantitative structure-activity relationship study on BTK inhibitors by modified multivariate adaptive regression spline and CoMSIA methods.

Deciphering Cathepsin K inhibitors: a combined QSAR, docking and MD simulation based machine learning approaches for drug design

Comparative In Silico Analysis and Functional Characterization of TANK-Binding Kinase 1–Binding Protein 1

Abstract 616: Integrating organotypic tissue slices and polypharmacology-based screening to map the toxicity landscape of kinase inhibitors

Machine learning-based classification models for non-covalent Bruton's tyrosine kinase inhibitors: predictive ability and interpretability

A computational approach to kinome-wide binding affinity profiling of small-molecular inhibitors using dynamic conformations of kinases

Receptor-guided 3D-QSAR studies, molecular dynamics simulation and free energy calculations of Btk kinase inhibitors

TANK-binding kinase 1 (TBK1): An emerging therapeutic target for drug discovery

Augmenting Bioactivity by Docking‐Generated Multiple Ligand Poses To Enhance Machine Learning and Pharmacophore Modelling: Discovery of New TTK Inhibitors as Case Study

Kinase-kernel models: accurate in silico screening of 4 million compounds across the entire human kinome

The discovery of a novel IκB kinase β inhibitor based on pharmacophore modeling, virtual screening and biological evaluation

In Silico study and design of some new potent threonine tyrosine kinase inhibitors using molecular docking simulation

Discovery of potent inhibitors for interleukin-2-inducible T-cell kinase: structure-based virtual screening and molecular dynamics simulation approaches

Combined 3D-QSAR, molecular docking and dynamics simulations studies to model and design TTK inhibitors

Strategy toward Kinase-Selective Drug Discovery